Inloggen
Inloggen
Of aanmelden met
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Registreer
Of aanmelden met
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepagina
  2. Aandelen
  3. Verenigd Koninkrijk
  4. London Stock Exchange
  5. AstraZeneca PLC
  6. Nieuws
  7. Andere talen
    AZN   GB0009895292

ASTRAZENECA PLC

(AZN)
  Rapport
Geschatte realtime Cboe Europe  -  16:08:13 02-02-2023
10253.00 GBX   -0.26%
15:51Tezspire voorgevulde pen van AstraZeneca en Amgen wordt goedgekeurd.
AN
15:38AstraZeneca's astmabehandeling Tezspire krijgt Amerikaanse FDA-goedkeuring voor zelftoediening
MT
01/02Analyse-GSK geeft weinig aanwijzingen over plannen om medicijnkastje aan te vullen
MR
OverzichtKoersenGrafiekenNieuwsRatingsAgendaOndernemingFinanciŽnConsensusHerzieningenBeursproductenFonds 
OverzichtAl het nieuwsAanbevelingen van analistenAndere talenPersberichtenOfficiŽle publicatiesSectornieuws
Nieuws in andere talen op ASTRAZENECA PLC
15:51AstraZeneca's, Amgen's Tezspire pre-filled pen wins approval
15:38AstraZeneca's Asthma Treatment Tezspire Wins US FDA Approval for Self Administration
15:10TEZSPIREģ approved for self-administration in the US with a new pre-filled pen
06:05WOCHENVORSCHAU: Termine bis 15. Februar 2023
00:32U.S. FDA approves GSK's anemia drug for patients on dialysis
01/02Analysis-GSK gives few clues on plans to replenish medicine cabinet
01/02FTSE 100 Closes Down 0.1% as Market Awaits Fed Meeting
01/02Astrazeneca : Transparency Directive - Form 6-K
01/02Telecoms, Natural Resources Lead European Equities Lower in Wednesday Trading
01/02GSK: bénéfice 2022 dopé par la scission des soins grand public
01/02Bolsa de Madrid: No es broma, Ņverdad?
01/02Pas de blague, hein ?
01/02Novartis says operating profit to grow again ahead of Sandoz spin-off
31/01Borse Europa in calo in vista riunione Bce, balza Unicredit
31/01European shares drop as focus shifts to cenbank meetings
31/01Las bolsas europeas caen con la atención en las reuniones de los bancos centrales
31/01Marketmind: Mind the gap
31/01WOCHENVORSCHAU: Termine bis 13. Februar 2023
30/01Drugmakers prevail in dispute over U.S. discount drug program
30/01AstraZeneca Doses First Patient in Phase 3 Study of Datopotamab Deruxtecan to Treat Lun..
30/01Daiichi begins Tropion-Lung07 phase 3 trial for lung cancer treatment
30/01AstraZeneca Enters Research Collaboration with Swedish Medtech Company Capitainer
30/01South Africa Signs Collaboration With Pharmaceutical Association Including GSK, AstraZe..
29/01'WamS': Bislang über 250 Corona-Impfschaden-Anträge genehmigt
27/01WOCHENVORSCHAU: Termine bis 10. Februar 2023
27/01WOCHENVORSCHAU/6. bis 12. Februar (6. KW)
27/01AstraZeneca : retrait de l'autorisation sur Evusheld aux USA
27/01L'appétit grandit
27/01Les valeurs à suivre à Paris et en Europe (actualisé)
27/01US FDA Cancels Emergency Use Nod For AstraZeneca's COVID-19 Drug
26/01ADRs End Higher; AstraZeneca, Diageo Trade Actively
26/01AstraZeneca loses emergency use authorisation for Evusheld
26/01U.S. FDA pulls authorization for AstraZeneca's COVID-19 treatment Evusheld
26/01AstraZeneca's COVID-19 Therapy Evusheld Is No Longer Authorized for Emergency Use by US..
26/01FDA Halts Authorization of AstraZeneca's Evusheld for Prophylactic Use
26/01Astrazeneca plc Announces Update on US Food and Drug Administration Emergency Use Autho..
26/01Astrazeneca : Update on US Food and Drug Administration Emergency Use Authorisation of Evu..
26/01U.S. FDA withdraws authorization for AstraZeneca's Evusheld
26/01Enhertu approved in the EU as the first HER2-directed therapy for patients with HER2-lo..
26/01Sector Update: Health Care Stocks Advance Pre-Bell Thursday
26/01GDP, Trade Data in Focus as Exchange-Traded Funds, Equity Futures Rise Pre-Bell Thursda..
26/01AstraZeneca, Daiichi Sankyo Say Enhertu Obtains European Approval for Treatment of HER2..
26/01AstraZeneca : l'UE approuve Enhertu pour le cancer du sein
26/01AstraZeneca's Enhertu approved in EU for breast cancer form
26/01AstraZeneca, Daiichi Sankyo's Enhertu Wins EU Nod for Breast Cancer
26/01Daiichi Sankyo and AstraZeneca’s ENHERTUģ Receives Approval in the EU as the First..
25/01Goldman likes UK banks; HSBC cuts Dr Martens
24/01ADRs End Lower; AstraZeneca, Can-Fite BioPharma Trade Actively
24/01FTSE 100 Closes Down 0.35% Amid Mixed PMI Data
24/01Pharma Stocks Weigh Down European Equities in Tuesday Trading
24/01Thermo Fisher Scientific Partners with AstraZeneca to Develop Solid Tissue and Blood-Ba..
24/01Ibex Medical Analytics Enters Collaboration with AstraZeneca and Daiichi Sankyo to Deve..
24/01FTSE 100 dips after weak economic data fans recession fears
24/01FTSE 100 lags as other indices make headway
24/01FTSE 100 lags as other indices make headway
24/01UK's FTSE 100 slips ahead of business activity data
24/01AstraZeneca Initiates Tender Offer For $2 Billion CinCor Takeover
23/01ADRs End Higher; AstraZeneca, Barclays Trade Actively
23/01Biotech IPO Window to Reopen in 2023 Following Muted Activity in 2022, Oppenheimer Says
23/01European Equities Rise as Consumer Confidence Grows
23/01AstraZeneca : ouverture de l'offre amicale sur CinCor
23/01Mehr digitaler Austausch im Kampf gegen Krebs in der EU
23/01AstraZeneca Unit Starts Tender Offer to Purchase CinCor Pharma
23/01AstraZeneca Begins Tender Offer to Acquire CinCor Pharma, Inc.
23/01Jefferies cuts Berkeley; HSBC cuts St James's
20/01FTSE 100 Closes Up 0.3% After Strong Start to Year
20/01FTSE 100 steadies after difficult week
20/01AstraZeneca : titre en retrait, un broker livre son conseil
20/01AstraZeneca Might Potentially Lose Billions in 2023
20/01AstraZeneca : Stifel abaisse sa cible, prudent pour 2023
20/01Bank of America raises Asos, boohoo to 'buy'
19/01Goldman Sachs cuts Relx but raises WPP
19/01Hutchmed's Lung Cancer Treatment Added to China's National Reimbursement Drug List
18/01Factbox-Moderna data puts the spotlight on RSV vaccines under development
18/01HUTCHMED Announces Inclusion of Orpathys in National Reimbursement Drug List in China
18/01Reunion Neuroscience Appoints Former Takeda, Pfizer Executive as Chief Medical Officer
18/01Hutchmed-AstraZeneca Cancer Drug Included in China’s Reimbursement Drug List
18/01How long will this bullish phase last?
18/01Analyst recommendations: Adobe, AstraZeneca, Morgan Stanley, Ora..
18/01AstraZeneca : Berenberg rehausse son objectif de cours
18/01Bank of America and Oddo BHF cut Whitbread
18/01Bolsa de Madrid: °Ya no baja!
18/01Ça baisse plus !
18/01Avis d'analystes du jour : L'Oréal, Capgemini, Technip Energies..
18/01UPS AND DOWNS "The FTSE ...
18/01Moderna data puts the spotlight on RSV vaccines under development
17/01FTSE 100 Closes Down 0.1% Amid AstraZeneca, Unilever Weakness
17/01FTSE 100 Closes Down 0.1% Amid AstraZeneca, -2-
17/01FTSE 100 Closes Down 0.1% Amid AstraZeneca, -3-
17/01Astrazeneca - Acquisition of Neogene Therapeutics completed
17/01AIM ImmunoTech, AstraZeneca Enter Collaborative Study for Pancreatic Cancer Treatment; ..
17/01AIM ImmunoTech Signs Pancreatic Cancer Clinical Research Deals With AstraZeneca, Erasmu..
17/01AIM ImmunoTech Inc. Enters into Pancreatic Cancer Clinical Research Agreements with Ast..
17/01FTSE 100 snaps four-day winning streak as Britain's Ocado slumps
16/01Innate Pharma bondit grâce à sa coopération avec Sanofi sur les cellules NK
16/01JUVENESCENCE Appoints Dr Richard Marshall CBE as CEO
16/01Acquisition of Neogene Therapeutics completed
16/01AstraZeneca completes acquisition of Neogene Therapeutics
16/01AstraZeneca : finalisation de l'acquisition de Neogene
16/01FTSE 100 seen flat; Just Eat and Sainsbury's partner
Volgende evenement op ASTRAZENECA PLC